Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Cardiology

Understanding Supravalvular Aortic Stenosis (SVAS)

At a Glance

Supravalvular Aortic Stenosis (SVAS) is a rare heart defect where the aorta narrows just above the aortic valve due to an elastin deficiency. While it requires lifelong monitoring and often surgical repair, the long-term survival rate after surgery is excellent, exceeding 90% at 15 years.

Hearing a diagnosis of a heart defect is frightening, but it is important to know that surgical outcomes for Supravalvular Aortic Stenosis (SVAS) are excellent. Research shows that long-term survival after repair is typically over 90% at 15 years [1][2].

This condition occurs when the aorta—the large artery that carries oxygen-rich blood from the heart to the rest of the body—is narrowed just above the aortic valve [3][4].

The Role of Elastin

The primary cause of SVAS is a deficiency in a protein called elastin, caused by a change in the ELN gene [5][6]. Elastin acts like a rubber band, allowing blood vessels to stretch and snap back with every heartbeat.

When there isn’t enough elastin, the body tries to compensate. This triggers a response at the cellular level:

  • Cell Overgrowth: The lack of elastin causes smooth muscle cells (the building blocks of the vessel wall) to multiply too quickly [7][8].
  • Narrowing: This abnormal buildup of cells and fibers thickens the wall of the aorta, making the opening through which blood must flow much smaller [9][10].

How SVAS Presents

SVAS is very rare in the general population, but it is a “cardinal feature” of Williams-Beuren syndrome (WBS), a genetic condition caused by a missing piece of chromosome 7 [3][11].

  • In Williams Syndrome: SVAS is highly prevalent and often diagnosed during routine screenings for the syndrome [12].
  • Isolated SVAS: In some cases, SVAS occurs on its own (non-syndromic) or runs in families due to a specific mutation in the ELN gene [3][13].

Common Symptoms

Many patients are diagnosed after a doctor hears a heart murmur (the sound of turbulent blood flow) during a routine check-up [14]. However, it is common for a murmur not to be heard immediately at birth, so parents should not feel guilty if it wasn’t caught on day one. Other signs may include:

  • Blood Pressure Differences: A noticeable difference in blood pressure between the right and left arms [15].
  • Activity Intolerance: Shortness of breath or becoming easily fatigued during play or exercise [16].
  • Growth Issues: Difficulty gaining weight or reaching developmental milestones in syndromic cases [11].

Long-Term Outlook and Care

The goal of treatment is to relieve the narrowing so the heart doesn’t have to work as hard to pump blood. A key metric doctors use to monitor this is the pressure gradient—a measurement of how hard the heart is straining to push blood past the blockage [17].

  • Surgical Success: Surgeons use “patches” to widen the narrowed section of the aorta, restoring normal blood flow [18].
  • Lifelong Monitoring: Because elastin deficiency can affect other vessels, including the coronary arteries (which supply the heart muscle) and the pulmonary arteries (which lead to the lungs), lifelong follow-up with a cardiologist is required [11][17].
  • Risk of Reintervention: While the initial surgery is usually very successful, some patients may eventually need a second procedure if the narrowing returns [19][20].

Common questions in this guide

What causes supravalvular aortic stenosis?
SVAS is primarily caused by a deficiency in a protein called elastin, which is linked to a change in the ELN gene. This lack of elastin causes cells in the blood vessel wall to overgrow and thicken, narrowing the aorta.
Is SVAS linked to Williams syndrome?
Yes, SVAS is a primary feature of Williams-Beuren syndrome, a genetic condition caused by a missing piece of chromosome 7. However, SVAS can also occur on its own or run in families without Williams syndrome.
What are the common symptoms of SVAS?
Many people are diagnosed after a doctor hears a heart murmur during a routine exam. Other common symptoms include shortness of breath during exercise, differences in blood pressure between the arms, and difficulty gaining weight in children.
How is SVAS treated?
The main treatment is surgical repair to widen the narrowed section of the aorta, often using patches. This relieves the strain on the heart, restores normal blood flow, and has excellent long-term success rates.
What is the long-term outlook after SVAS surgery?
Because elastin deficiency can affect other blood vessels over time, lifelong monitoring by a cardiologist is essential. While initial surgeries are highly successful, some patients may need a second procedure if the narrowing returns.
What does the pressure gradient mean for SVAS?
The pressure gradient is a measurement of how hard your heart has to strain to push blood past the narrowed area of the aorta. Doctors use this measurement to determine if and when surgery is necessary.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is the current pressure gradient across the aorta, and how does it compare to the 'threshold' for surgical intervention?
  2. 2.Were the coronary artery openings (ostia) clearly visible on the imaging, and are they affected by the narrowing?
  3. 3.Does the patient have any narrowing in the pulmonary arteries in addition to the aorta?
  4. 4.What is our long-term plan for monitoring, and how often will we need follow-up echocardiograms?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Surgical Outcome of Supra-Valvular Aortic Stenosis: A 50-Year Single-Centre Experience.

    Schaeffer T, Bellastrada T, Kienmoser D, et al.

    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2026; (68(2)) doi:10.1093/ejcts/ezag062.

    PMID: 41689472
  2. 2

    Long-term Surgical Prognosis of Primary Supravalvular Aortic Stenosis Repair.

    Wu FY, Mondal A, Del Nido PJ, et al.

    The Annals of thoracic surgery 2019; (108(4)):1202-1209 doi:10.1016/j.athoracsur.2019.04.094.

    PMID: 31229480
  3. 3

    Novel ELN mutation in a Japanese family with a severe form of supravalvular aortic stenosis.

    Sugiyama K, Horigome H, Lin L, et al.

    Molecular genetics & genomic medicine 2019; (7(11)):e986 doi:10.1002/mgg3.986.

    PMID: 31560829
  4. 4

    Toward a rational therapeutic for elastin related disease: Key considerations for elastin based regenerative medicine strategies.

    Ganjibakhsh M, Tkachenko Y, Knutsen RH, Kozel BA

    Matrix biology : journal of the International Society for Matrix Biology 2025; (138()):8-21 doi:10.1016/j.matbio.2025.03.003.

    PMID: 40158781
  5. 5

    [Genetic analysis of a child with atypical Williams-Beuren syndrome presenting as supravalvular aortic stenosis].

    Wu D, Zhang M, Gao Y, et al.

    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2020; (37(4)):475-478 doi:10.3760/cma.j.issn.1003-9406.2020.04.028.

    PMID: 32219841
  6. 6

    Genetic Testing for Supravalvar Aortic Stenosis: What to Do When It Is Not Williams Syndrome.

    Stephens SB, Novy T, Spurzem GN, et al.

    Journal of the American Heart Association 2024; (13(8)):e034048 doi:10.1161/JAHA.123.034048.

    PMID: 38591341
  7. 7

    Integrin β3 inhibition is a therapeutic strategy for supravalvular aortic stenosis.

    Misra A, Sheikh AQ, Kumar A, et al.

    The Journal of experimental medicine 2016; (213(3)):451-63 doi:10.1084/jem.20150688.

    PMID: 26858344
  8. 8

    Deficient Circumferential Growth Is the Primary Determinant of Aortic Obstruction Attributable to Partial Elastin Deficiency.

    Jiao Y, Li G, Korneva A, et al.

    Arteriosclerosis, thrombosis, and vascular biology 2017; (37(5)):930-941 doi:10.1161/ATVBAHA.117.309079.

    PMID: 28254817
  9. 9

    Elastin, arterial mechanics, and stenosis.

    Lin CJ, Cocciolone AJ, Wagenseil JE

    American journal of physiology. Cell physiology 2022; (322(5)):C875-C886 doi:10.1152/ajpcell.00448.2021.

    PMID: 35196168
  10. 10

    Elastin haploinsufficiency in mice has divergent effects on arterial remodeling with aging depending on sex.

    Hawes JZ, Cocciolone AJ, Cui AH, et al.

    American journal of physiology. Heart and circulatory physiology 2020; (319(6)):H1398-H1408 doi:10.1152/ajpheart.00517.2020.

    PMID: 33035438
  11. 11

    Long-term surgical outcomes of congenital supravalvular aortic stenosis: a systematic review, meta-analysis and microsimulation study.

    Meccanici F, Notenboom ML, Meijssen J, et al.

    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2024; (65(1)) doi:10.1093/ejcts/ezad360.

    PMID: 37889257
  12. 12

    Long-term cardiovascular outcome of Williams syndrome.

    Cha SG, Song MK, Lee SY, et al.

    Congenital heart disease 2019; (14(5)):684-690 doi:10.1111/chd.12810.

    PMID: 31166070
  13. 13

    Frequent intragenic microdeletions of elastin in familial supravalvular aortic stenosis.

    Hayano S, Okuno Y, Tsutsumi M, et al.

    International journal of cardiology 2019; (274()):290-295 doi:10.1016/j.ijcard.2018.09.032.

    PMID: 30228022
  14. 14

    Diagnosis of membranous supravalvular aortic stenosis with severe aortic valve insufficiency.

    Chen R, Cao JF, Wang ZJ, et al.

    Journal of clinical ultrasound : JCU 2024; (52(3)):315-317 doi:10.1002/jcu.23621.

    PMID: 38009956
  15. 15

    Severe Congenital Obstruction of the Left Main Coronary Artery Coexisting With Supravalvular Aortic Stenosis in Williams Syndrome: A Dangerous Association.

    Szaflik K, Kaźmierczak P, Moll JJ, Moll JA

    World journal for pediatric & congenital heart surgery 2016; (7(2)):216-9 doi:10.1177/2150135115586269.

    PMID: 26582765
  16. 16

    Clinical course and outcomes of supravalvular aortic stenosis in adults.

    de Keijzer AR, Keuning ZA, Meccanici F, et al.

    Open heart 2025; (12(1)) doi:10.1136/openhrt-2025-003355.

    PMID: 40436430
  17. 17

    A successful surgical repair for supravalvular aortic stenosis with a bicuspid valve and malpositioned coronary orifices by partial Brom's technique: a case report.

    Hara M, Honda Y, Kaga S, et al.

    Surgical case reports 2024; (10(1)):242 doi:10.1186/s40792-024-02039-w.

    PMID: 39443405
  18. 18

    Surgical Techniques in Management of Supravalvular Aortic Stenosis in Children.

    Ibarra C, Spigel Z, John R, et al.

    The Annals of thoracic surgery 2021; (111(6)):2021-2027 doi:10.1016/j.athoracsur.2020.06.118.

    PMID: 32946844
  19. 19

    Genetic Diagnosis and the Severity of Cardiovascular Phenotype in Patients With Elastin Arteriopathy.

    Min S, Kinnear C, D'Alessandro LCA, et al.

    Circulation. Genomic and precision medicine 2020; (13(6)):e002971 doi:10.1161/CIRCGEN.120.002971.

    PMID: 32960096
  20. 20

    Long-term Outcomes After Surgical Intervention for Congenital Supravalvar Aortic Stenosis in Children.

    Zinyandu T, Knight JH, Thomas AS, et al.

    The Annals of thoracic surgery 2024; (117(5)):965-972 doi:10.1016/j.athoracsur.2024.01.020.

    PMID: 38302053

This page provides educational information about Supravalvular Aortic Stenosis (SVAS). It does not replace professional medical advice; always consult your cardiologist to discuss your or your child's specific diagnosis and treatment plan.

Get notified when new evidence is published on Supravalvular aortic stenosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.